Hi Casey,
Thanks for responding! I appreciate the comment to keep researching, but I am a pretty quick study and not sure how much more reading will accomplish (I only put a small fraction of what I have looked at in my original post).
As far as NCCN guidelines maybe some clarification on my analysis is in order. I believe you are referring to the Guidelines for Patients (
link), page 44 where it states:
"Active survellance is also an option if you are likely to live 20 or more years."
but it also states:
"This option may be of interest if you're younger and want to avoid side effects until treatment is clearly needed."
In my case, I am not overly concerned of the side effects.
What I am referring to is the Physician Guidelines (
link) where I am classified as a Very Low Risk (ref: PROS-1) so therefore use PROS-2 for Initial Therapy. In PROS-2, under Very Low Risk I have a life expectancy of greater than 20 years so it says to use the Initial Therapy for Low Risk. If you then go to this section of PROS-2 (same page), I have a life expectancy of greater than 10 years so it says I have all three options (it doesn't preclude one over the other) AS, radiation or surgery. BUT, AS has a footnote (e) that takes you to PROS-B where it states:
"Active surveillance is usually appropriate for men with very low-risk prostate cancer when life expectancy is < 20 y or men with low-risk prostate cancer when life expectancy is <10 y."
It does not state it is an option or consideration for men with a life expectancy of greater than 20 years. I also did not find anything relevant in the discussion pages that follow the charts.
In the end it is a bit muddy around AS (given the verbiage in the patient guidelines) but only AS has an asterisk next to it. In reality, to me, it means any option is viable and nobody can be wrong... do what you and our physician(s) think is best for you.
Thanks again!